BiPAP combined with oxygen-driven budesonide nebulization improves clinical indicators in acute exacerbation of chronic obstructive pulmonary diseases with type 2 diabetes
YAO Guanjin
LIN Huibin
HUANG Yaoguang
MA Biman
Abstract:Objective To observe the efficacy of bi-level positive airway pressure ventilator(BiPAP)and oxygen-driven aerosol inhalation of budesonide in patients with acute exacerbation of chronic obstructive pulmonary diseases(AECOPD)and type 2 diabetes mellitus(T2DM).Methods A total of 110 AECOPD patients with T2DM were randomly treated with BiPAP(control group)or BiPAP plus oxygen-driven budesonide nebulization(observation group)for 7 days.Clinical efficacy,adverse reactions,blood gas,vital signs,inflammatory response,stress response,glucose metabolism,and pulmonary function indexes were compared between two groups.Results Compared with control group,PaCO2,heart rate,respiration,hs-CRP,WBC,MDA,DI were significantly decreased,while PaO2,SOD,FEV1%and FEV1/FVC increased in observation group(P<0.01 or 0.05).The curative effect was better in observation group than in control group(P<0.05).Conclusion BiPAP combined with oxygen-driven budesonide nebulization can improve the curative effect as well as blood gas,vital signs,inflammatory response,stress response and pulmonary function in patients with AECOPD and T2DM.
Keywords:acute exacerbation of chronic obstructive pulmonary diseasestype2 diabetesbilevel positive airway pressure ventilatoroxygen driven nebulizationbudesonide
Publication Date:2025-04-30
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:5( 189-193 )
